Merck & Co., Inc. (MRK): Share Repurchases
$5.08B
Year ended 2025-12-31
$4.21B
Trailing 12 months to 2026-06-30
+31.7%
5-year compound annual growth
+2.0%
10-year compound annual growth
| Period ended | Share Repurchases | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $5.08B | +289.3% | 2026-02-24, From 2025-01-01 |
| 2024-12-31 | $1.31B | -3.0% | 2026-02-24, From 2024-01-01 |
| 2023-12-31 | $1.35B | n/a | 2026-02-24, From 2023-01-01 |
| 2022-12-31 | $0 | -100.0% | 2025-02-25, From 2022-01-01 |
| 2021-12-31 | $840.00M | -34.4% | 2024-02-26, From 2021-01-01 |
| 2020-12-31 | $1.28B | -73.2% | 2023-02-24, From 2020-01-01 |
| 2019-12-31 | $4.78B | -47.4% | 2022-02-25, From 2019-01-01 |
| 2018-12-31 | $9.09B | +126.5% | 2021-02-25, From 2018-01-01 |
| 2017-12-31 | $4.01B | +16.9% | 2020-02-26, From 2017-01-01 |
| 2016-12-31 | $3.43B | -18.0% | 2019-02-27, From 2016-01-01 |
| 2015-12-31 | $4.19B | -45.7% | 2018-02-27, From 2015-01-01 |
| 2014-12-31 | $7.70B | +18.2% | 2017-02-28, From 2014-01-01 |
| 2013-12-31 | $6.52B | +151.5% | 2016-02-26, From 2013-01-01 |
| 2012-12-31 | $2.59B | +34.9% | 2015-02-27, From 2012-01-01 |
| 2011-12-31 | $1.92B | +20.6% | 2014-02-27, From 2011-01-01 |
| 2010-12-31 | $1.59B | n/a | 2013-02-28, From 2010-01-01 |
| 2009-12-31 | $0 | -100.0% | 2010-03-01, From 2009-01-01 |
| 2008-12-31 | $2.73B | +90.6% | 2011-02-28, From 2008-01-01 |
| 2007-12-31 | $1.43B | n/a | 2010-03-01, From 2007-01-01 |
Share Repurchases at similar companies
| Company | Year ended | Share Repurchases | Change YoY |
|---|---|---|---|
| Merck & Co., Inc. (MRK) | 2025-12-31 | $5.08B | +289.3% |
| Eli Lilly & Co (LLY) | 2025-12-31 | $4.11B | +64.3% |
| Pfizer Inc (PFE) | 2024-12-31 | $0 | n/a |
| AbbVie Inc. (ABBV) | 2025-12-31 | $980.00M | -42.6% |
| Bristol Myers Squibb Co (BMY) | 2025-12-31 | $0 | n/a |
| Johnson & Johnson (JNJ) | 2025-12-28 | $5.95B | +144.8% |
| Abbott Laboratories (ABT) | 2025-12-31 | $893.00M | -31.0% |
| Regeneron Pharmaceuticals, Inc. (REGN) | 2025-12-31 | $3.44B | +32.1% |
| Viatris Inc (VTRS) | 2025-12-31 | $500.50M | +100.2% |
Compare MRK, LLY, PFE, ABBV side by side · Screen every company in Pharmaceutical Preparations ↗